The IFNL3 gene helps control part of your body’s early defense against viruses by sending signals that tell nearby cells to strengthen their protection. This gene helps your body respond to infections that affect tissues such as the liver and airways. When its activity differs, the body may be less likely to clear some viral infections, especially hepatitis C, without treatment. The IFNL3 gene became well known during the hepatitis C era, when it was often discussed under its older name, the IL28B gene, in testing and research.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes contain the directions for making proteins, the functional parts of cells. Other genes mainly control when certain processes happen, where they take place, and how strongly they occur. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. If you want to look into this topic more deeply, you can find more in the LearnHub.
Overview
IFNL3Gene function
What if the gene works
The IFNL3 gene helps your body make interferon lambda 3, a signal protein that supports antiviral defenses. It helps cells in tissues like the airways and gut switch on nearby immune protection.
Risk
What if the gene does not work
Changes in the IFNL3 gene can range from milder to more severe and may weaken interferon lambda 3 signaling, so cells switch on antiviral genes less effectively. This can alter immune messaging at surfaces like liver and airways.
Treatment
What does that mean for your treatment
No treatment or management approach based on the IFNL3 gene is currently established in clinical guidelines. The IFNL3 gene is still studied as a biomarker of antiviral response, especially in hepatitis C, but it does not currently guide routine drug choice.
Gene function
What if the gene works
Your body uses the IFNL3 gene as part of its early virus defense. It helps cells send a focused immune message, especially in tissues that line body surfaces. Understanding how the IFNL3 gene helps your immune system respond to viruses makes it easier to see why this gene matters in everyday cell protection.
Cells use the IFNL3 gene to make a signaling protein that alerts nearby cells to viral infection. This message helps those cells switch on antiviral programs that make it harder for viruses to multiply.
The IFNL3 signal works most strongly in cells lining body surfaces such as the airways and intestines. This supports local protection in places where viruses often first enter the body.
IFNL3 helps create a more targeted immune response rather than a broad whole body alarm. This supports antiviral defense while keeping the response centered in the tissues receiving the signal.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help create normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants linked to the IFNL3 gene affect control regions, so the main issue is how IFNL3 gene variants influence function by changing how strongly the gene is switched on during antiviral signaling. These changes can alter how much IFNL3 is made and how consistently nearby cells receive that signal. Most are milder regulatory variants with modest effects, while more disruptive variants may cause a larger drop in gene activity or protein output.
How variants are linked to conditions
Variants in the IFNL3 gene are most strongly linked to hepatitis C, especially whether a person clears the infection on their own and how well interferon based treatment works. In studies, some IFNL3 gene variants and hepatitis C treatment response patterns have been linked to a higher chance of viral clearance, while others are linked to lower response rates. These variants influence risk and treatment trends rather than guarantee a specific outcome.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
Changes near the IFNL3 gene can affect how likely someone is to clear hepatitis C on their own or respond to some older hepatitis C treatments. That effect can also be shaped by the hepatitis C strain, how much virus is present, and liver health, so IFNL3 is only one part of the picture.
Inheritance of IFNL3 variants
There is not yet a broadly confirmed, disease-specific Mendelian inheritance pattern for the IFNL3 gene, because IFNL3 gene changes are mainly studied for how they may influence traits such as the body’s response to certain viral infections rather than causing a single inherited condition. In practice, how IFNL3 gene variants are inherited follows the usual pattern for genes on the numbered chromosomes: you inherit one copy from each parent. The IFNL3 gene is located on chromosome 19, which is an autosome, so inheritance is generally the same in males and females.
What does my IFNL3 result mean for my family?
There is not a broadly confirmed single-gene inheritance pattern for IFNL3 tied to a specific inherited condition. IFNL3 results are usually about differences that can influence tendencies, such as how the body responds to certain infections or treatments, rather than showing that relatives are likely to have a clear inherited condition for this gene.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the IFNL3 gene, a genetic test for IFNL3 variants uses a saliva sample or blood sample. The lab reads small parts of your DNA and compares them with the usual sequence. Results identify which variant is present and can help clarify inherited differences in this gene.
When should I consider getting a genetic test?
There is not a broadly established reason to test the IFNL3 gene in routine care today. Decisions about genetic testing are usually based on your overall medical history, such as hepatitis C care, and are best made with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it can tell you varies with the condition and the specific kind of variant. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, particularly those affected by many genes, genetic information offers context instead of certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result can give a clear answer. For things like medication response, genetic results may also help put a person’s experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles certain medicines and how strongly you respond to them. This helps explain why the same treatment may work well for one person, work less well for another, or cause more side effects in someone else. These differences are common and can influence how quickly a drug is broken down, how much reaches its target, or how sensitive the body is to it. Genetics is one part of the picture, alongside age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way someone responds to medication. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. With many medicines, genes can influence how strongly a drug works or how the body processes it. This information can help support treatment choices that are more informed and more individualized. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the IFNL3 gene
When should I seek medical advice?
There isn't a broadly confirmed role for this gene in guiding medicine choices right now, so general questions about medicines or side effects are best discussed with your doctor. IFNL3 has been studied mainly in hepatitis C treatment, where certain gene changes were linked to how well some older interferon-based treatments worked.
History
The IFNL3 gene became widely recognized during the hepatitis C era, when researchers discovered that common variants near this gene were strongly linked to how likely a person was to clear the virus or respond to interferon based treatment. In recent decades, awareness of this gene’s role has grown. Early studies often referred to it as IL28B, and that name appeared in many medical papers and test reports before the current name IFNL3 became standard. From these first observations, research expanded steadily. The finding was a milestone for personalized medicine because it helped explain why treatment results differed so much from one person to another. As newer hepatitis C drugs changed care, IFNL3 remained an important chapter in the history of genetic testing and liver medicine.